Treatment of macular degeneration with proton beams

• Published in: Medical physics (Lancaster) 1999-05, Vol.26 (5), p.777-782
• Main Authors: Moyers, M. F., Galindo, R. A., Yonemoto, L. T., Loredo, L., Friedrichsen, E. J., Kirby, M. A., Slater, J. D., Slater, J. M.
• Format: Article
• Language: English
• Subjects: biological effects of ionising particles; biomembranes; blood vessels; Brain; Cameras; Cobalt; Collimators; Diseases; Dose-Response Relationship, Radiation; dosimetry; Dosimetry/exposure assessment; Effects of ionizing radiation on biological systems; eye; geriatrics; Humans; Ionization chambers; Laser beam effects; macular degeneration; Macular Degeneration - radiotherapy; Membranes, bilayers, and vesicles; Physiological optics; proton beam; proton effects; Protons; Protons - therapeutic use; radiation therapy; Radiotherapy Dosage; Silver; Technology, Radiologic; Treatment strategy; Visual acuity
• ISSN: 0094-2405; 2473-4209
• DOI: 10.1118/1.598587

Subfoveal neovascular membranes (SNVMs) are a leading cause of severe visual loss in the elderly in the United States. Previously, the only treatment that could halt progression of this disease was laser photocoagulation, which was, however, accompanied by immediate reduction in visual acuity. A single narrow proton beam was used to irradiate 45 patients to either 8 or 14 Cobalt Gray Equivalent. The alignment technique and dosimetry of these treatments are described. The proton beam direction, range, and modulation were planned with the assistance of an eye-specific planning program. A single anterior beam was used, with patients looking nasally toward a blinking fixation light at an angle of 30°. Patients were aligned using a light field projected through a slit collimator. Patients’ positions were monitored during treatment with a short-focal-length camera. Depth dose in a flat phantom was measured with a small-diameter parallel plate ionization chamber. Lateral profiles were measured at several depths with silver halide film. Each treatment session lasted 15 min, of which 1 min consisted of beam delivery. The proton beam stopped in the orbital cavity, delivering no primary proton dose to the brain. Dose to the center of the lens of the involved eye was less than 0.5% of the dose delivered to the macula. Treatments of SNVMs with proton beams require only a short visit to the hospital, little immobilization effort, and a minimal amount of treatment room and beam time. Compared to previous treatment trials using x-ray beams, the dose to nonocular tissues is reduced significantly.